Respiratory health harms often follow flooding: Taking these steps can help
Tips to leverage neuroplasticity to maintain cognitive fitness as you age
Can white noise really help you sleep better?
Celiac disease: Exploring four myths
What is prostatitis and how is it treated?
What is Cushing syndrome?
Exercises to relieve joint pain
Think your child has ADHD? What your pediatrician can do
Foam roller: Could you benefit from this massage tool?
Stepping up activity if winter slowed you down
Charlie Schmidt
Editor, Harvard Medical School Annual Report on Prostate Diseases
Charlie Schmidt is an award-winning freelance science writer based in Portland, Maine. In addition to writing for 天博体育 Publishing, Charlie has written for Science magazine, the Journal of the National Cancer Institute, Environmental Health Perspectives, Nature Biotechnology, and The Washington Post.
Posts by Charlie Schmidt
Cancer
Combining surgery, radiation, and hormonal therapy dramatically extends survival in men with advanced prostate cancer
Charlie Schmidt
Adding hormonal therapy to radiation lengthens survival in men with recurring prostate cancer
Cancer
Adding hormonal therapy to radiation lengthens survival in men with recurring prostate cancer
Cancer
New imaging technique may help some men avoid prostate biopsy
Cancer
Immediate radiation when PSA levels spike after prostate cancer surgery helps reduce risk of recurrence
Men's Health
New study recommends immediate radiation when PSA Levels spike after prostate cancer surgery
Cancer
Treatment versus monitoring of prostate cancer: Survival rates the same after 10 years
Men's Health
Treatment versus monitoring of prostate cancer: Survival rates the same after 10 years
Charlie Schmidt
Treating the primary tumor can improve survival in men whose prostate cancer has spread
Cancer
Treating the primary tumor can improve survival in men whose prostate cancer has spread
Cancer
New urine test predicts high-grade prostate cancer
Charlie Schmidt
New urine test predicts high-grade cancer
Cancer
The risks of active surveillance for men with intermediate-risk prostate cancers
Men's Health
Risks of active surveillance for men with intermediate-risk prostate cancers
Charlie Schmidt
Long-term hormonal therapy benefits men with locally advanced prostate cancer
Cancer
Long-term hormonal therapy benefits men with locally advanced prostate cancer
Men's Health
Promising results for a targeted drug in advanced prostate cancer
Charlie Schmidt
Does fewer PSA tests mean less prostate cancer?
Cancer
Does fewer PSA tests mean less prostate cancer?
Cancer
Active surveillance is safe for low-risk prostate cancers
Cancer
Active surveillance is safe for low-risk prostate cancers
Men's Health
Following low-risk prostate cancers before starting treatment becoming more common
Cancer
Following low-risk prostate cancers before starting treatment becoming more common
Cancer
Heart-healthy diet boosts survival in men with low-risk prostate cancer
Respiratory health harms often follow flooding: Taking these steps can help
Tips to leverage neuroplasticity to maintain cognitive fitness as you age
Can white noise really help you sleep better?
Celiac disease: Exploring four myths
What is prostatitis and how is it treated?
What is Cushing syndrome?
Exercises to relieve joint pain
Think your child has ADHD? What your pediatrician can do
Foam roller: Could you benefit from this massage tool?
Stepping up activity if winter slowed you down
